Global leader in healthcare products selects clinivation WorldView as its most comprehensive, authoritative resource for building its medical product submissions and registrations worldwide.
Natick, MA, January 2, 2008 – clinivation, Inc. announced today that Covidien, Ltd. (NYSE: COV) has selected clinivation WorldView® Online Regulatory Intelligence web service.
“We are pleased that Covidien has selected clinivation WorldView as their source for comprehensive, authoritative, and up-to-date regulatory intelligence,” remarked Richard Morroney, R.A.C., C.Q.A., clinivation’s Vice President of Quality and Regulatory Solutions. “With information on >99% of the world markets, Covidien will be able to stay current on ever-changing regulations,” he continued.
Clinivation WorldView is your most comprehensive, authoritative, and up-to-date resource for building all of your medical device submissions and registrations worldwide. Clinivation WorldView also interoperates with clinivation Global® enterprise software to make building and tracking medical device submissions and registrations easier than ever before.
About Covidien, Ltd.
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in five segments: Medical Devices, Pharmaceutical Products, Imaging Solutions, Medical Supplies and Retail Products. With 2007 revenue of $10 billion, Covidien has more than 43,000 employees worldwide in 57 countries, and its products are sold in over 130 countries.
Please visit www.covidien.com to learn more.